Product
Etoricoxib 90 mg
1 clinical trial
1 indication
Indication
Ankylosing spondylitisClinical trial
A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patients With Ankylosing SpondylitisStatus: Completed, Estimated PCD: 2014-11-12